Deep-learning design produced soluble analogues of membrane-protein folds with preserved binding functions
A deep-learning pipeline based on inversion of AlphaFold2 and ProteinMPNN designed soluble proteins with claudin, rhomboid-protease and GPCR-like folds. Experiments reported stable, folded soluble designs and structural agreement with target folds. The researchers grafted functional motifs, including a ghrelin-receptor epitope that bound its antibody and active/inactive A2A-receptor-like designs that differed in mini-Gs binding; a binding-site knockout served as a control.
Technology: AF2seq deep-learning backbone design with ProteinMPNN sequence design
Family ProteinMPNN: profile · models page
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Experiments reported stable, folded soluble designs and structural agreement with target folds.
- Still unknown: This is a protein-design proof of concept with in-vitro biophysical and binding assays; the analogues are not native membrane receptors and do not demonstrate signaling, drug activity or therapeutic efficacy. The GPCR analogues tested binding to mini-Gs in conformation-designed constructs. The separate live-catalog record on designed proteins modulating dopamine D1 receptor signaling reports a different binder/target and signaling result; this paper reports soluble receptor-fold analogues and binding assays, not D1 signaling modulation.
- AI role: The deep-learning design pipeline generated soluble analogues of complex membrane-protein folds and the scaffolds into which native functional motifs were grafted. The study tested solubility, thermal stability, structural accuracy and selected binding functions experimentally, including conformation-specific A2A-receptor-like constructs.
Evidence sources: https://www.nature.com/articles/s41586-024-07601-y
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 184 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.